Financhill
Back

G1 Therapeutics Stock Predictions

G1 Therapeutics Stock Forecast

  • Is G1 Therapeutics Stock Undervalued?
    The current G1 Therapeutics [GTHX] share price is $4.13. The Score for GTHX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • GTHX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will G1 Therapeutics Stock Go Up Next Year?

Data Unavailable

G1 Therapeutics Stock Rating

Data Unavailable

G1 Therapeutics Stock Price History

Is GTHX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTHX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
g1therapeutics.com

52-Week Data

52-Week High:
5.00
52-Week Low:
1.08

Prediction Charts

Market Cap:
215.58M
Price in USD:
4.13
Volume:
995.08K
Beta:
1.85

Technical Analysis

SMA50:
3.81
SMA100:
3.60
SMA200:
2.64
52-Wk Change:
34.09%

Stock Predictions

  • Is G1 Therapeutics stock public?
    Yes, G1 Therapeutics is a publicly traded company.
  • What is the G1 Therapeutics stock quote today?
    The G1 Therapeutics stock price is 4.13 USD today.
  • How to buy G1 Therapeutics stock online?
    You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-12 4.65 4.55 4.70 4.39
Apr-15 4.61 4.31 4.61 4.18
Apr-16 4.25 4.08 4.32 3.99
Apr-17 4.15 4.28 4.35 4.09
Apr-18 4.31 4.16 4.31 4.04
Apr-19 4.13 4.12 4.31 3.97
Apr-22 4.15 4.10 4.20 3.95
Apr-23 4.15 4.19 4.32 4.10
Apr-24 4.19 3.99 4.24 3.94
Apr-25 3.93 3.86 3.93 3.77
Apr-26 3.85 3.99 4.05 3.84
Apr-29 3.95 3.72 4.03 3.70
Apr-30 3.71 3.77 3.86 3.65
May-1 3.52 4.13 4.24 3.52

G1 Therapeutics Earnings

Data Unavailable

G1 Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $0.45 per share.

* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.